Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Neurosteroids may help treat disorders with too much dopamine activity.

New compounds show promise as nonsteroidal treatments for hair loss.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

A new method to make finasteride for hair loss treatment was developed.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.